CYTOTOXIC CD4+ T CELLS AS NOVEL IMMUNOTHERAPY IN CLL AND OTHER B-CELL MALIGNANCIES

Project Details

AcronymKILLERCD4-CLL
StatusActive
Effective start/end date1/01/2331/12/24